Unknown

Dataset Information

0

MiR-200a regulates PD-L1 and predicts response to immune checkpoint inhibitors in advanced non-small cell lung cancer

ABSTRACT:

SUBMITTER: Kaneko A 

PROVIDER: S-EPMC12337029 | biostudies-literature | 2025 Jul

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown PD-1/PD-L1 checkpoint inhibitors in advanced hepatocellular carcinoma immunotherapy.
| S-EPMC9806143 | biostudies-literature
Unknown Small-molecule inhibitors of PD-1/PD-L1 immune checkpoint alleviate the PD-L1-induced exhaustion of T-cells.
| S-EPMC5641120 | biostudies-literature
Unknown Di-bromo-Based Small-Molecule Inhibitors of the PD-1/PD-L1 Immune Checkpoint.
| S-EPMC7584369 | biostudies-literature
Unknown Novel Biomarkers of Dynamic Blood PD-L1 Expression for Immune Checkpoint Inhibitors in Advanced Non-Small-Cell Lung Cancer Patients.
| S-EPMC8085403 | biostudies-literature
Unknown Advanced non-small cell lung cancer: the role of PD-L1 inhibitors.
| S-EPMC5994502 | biostudies-literature
Unknown Bioactive Macrocyclic Inhibitors of the PD-1/PD-L1 Immune Checkpoint.
| S-EPMC6400216 | biostudies-literature
Unknown PD-1/PD-L1 pathway inhibitors in advanced prostate cancer.
| S-EPMC6317331 | biostudies-literature
Unknown Epithelial-mesenchymal transition induced by tumor cell-intrinsic PD-L1 signaling predicts a poor response to immune checkpoint inhibitors in PD-L1-high lung cancer.
| S-EPMC11231337 | biostudies-literature
Unknown MiR-340-5p regulates PD-L1 and predicts pembrolizumab response in extranodal NK/T-cell lymphoma.
| S-EPMC11861318 | biostudies-literature
Unknown The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma.
| S-EPMC4497957 | biostudies-literature